Nocebo, Somatisation, and Physiological Sensitivity
Why your body’s response is real, even when the trigger isn’t what it seems
In clinical practice, there is a recurring and often misunderstood pattern: patients experience very real, sometimes debilitating symptoms, yet investigations are normal, treatments are poorly tolerated, and symptoms fluctuate in ways that seem disproportionate or unpredictable.
This is not imagined. It is not “just psychological.”
It is a complex interaction between the brain, body, and expectations.
Three concepts help us understand this: the nocebo effect, somatisation, and physiological sensitivity. When brought together, they offer a powerful, compassionate, and evidence-based framework for understanding symptoms that don’t fit neatly into traditional biomedical models.
The nocebo effect: when expectation shapes physiology
Most people are familiar with the placebo effect, where positive expectations improve outcomes. The nocebo effect is its counterpart: negative expectations leading to worse symptoms or side effects.
This is not hypothetical. It is reproducible, measurable, and clinically significant.
A large systematic review found that nocebo effects can be reliably induced across a wide range of physical symptoms, including pain, nausea, and fatigue . Another meta-analysis demonstrated moderate to large effect sizes, meaning the impact is not trivial .
At a physiological level, nocebo responses are not “just thoughts.” They involve:
Activation of pain pathways
Changes in autonomic nervous system responses (heart rate, skin conductance)
Neurochemical shifts linked to stress and anticipation
Experimental studies show that negative expectations can directly amplify pain-related physiological responses, not just subjective perception .
In simple terms:
What the brain predicts, the body begins to experience.
How nocebo responses are learned
Nocebo effects do not arise randomly. They are learned through multiple pathways:
1. Verbal suggestion
Being told about possible side effects increases the likelihood of experiencing them.
Expectation alone is one of the strongest predictors of symptom development .
2. Conditioning
If a person has previously experienced symptoms in a particular context (for example, medication, hormonal changes, or stress), the brain begins to associate that context with future symptoms.
3. Social learning
Symptoms can be learned by observing others. Studies show that watching someone else experience pain can increase your own pain response .
4. Healthcare interactions
Even subtle cues from clinicians, including wording and non-verbal communication, can influence symptom experience.
This matters deeply in women’s health, where many patients have accumulated years of negative or dismissive medical experiences.
Somatisation: when the body expresses distress
Somatisation refers to the expression of psychological or emotional distress through physical symptoms.
This does not mean symptoms are “caused by the mind” in a simplistic sense. Rather, it reflects how closely integrated emotional and physiological systems are.
The brain continuously interprets signals from the body and the environment. When this system becomes sensitised, it can:
Amplify normal bodily sensations
Misinterpret benign signals as threatening
Generate real physical symptoms in the absence of structural disease
Importantly, somatisation exists on a spectrum. Many patients with conditions like:
PMS and PMDD
Perimenopause
IBS
Chronic pain
Functional neurological symptoms
have overlapping features of central sensitisation and somatic amplification.
Physiological sensitivity: a heightened nervous system
Some individuals are more biologically sensitive to internal and external stimuli. This is sometimes described as:
Central sensitisation
Interoceptive sensitivity
Nervous system dysregulation
In these individuals, the threshold for symptom generation is lower.
Research suggests that:
Negative expectations amplify sensory perception, especially pain and itch
Anxiety is associated with stronger nocebo responses
Prior experiences and symptom history increase susceptibility
This creates a feedback loop:
Sensitivity → expectation → symptom → reinforcement → increased sensitivity
Over time, this loop can become deeply ingrained.
Why this matters in clinical practice
Understanding this triad changes how we interpret several common scenarios:
1. “I react badly to everything”
Patients who report multiple medication intolerances are often experiencing nocebo-driven physiological responses, not pharmacological toxicity.
2. “My symptoms move or change”
This reflects dynamic nervous system processing, not inconsistency or exaggeration.
3. “Tests are normal but I feel awful”
Investigations measure structure.
These conditions are about function and regulation.
4. “Hormones make everything worse”
Hormonal fluctuations can act as amplifiers of an already sensitised system, particularly in PMDD and PME.
The brain-body model: integrating it all
The most helpful way to understand this is through a biopsychosocial model:
Biological: genetics, hormones, nervous system sensitivity
Psychological: expectations, anxiety, prior experiences
Social: medical interactions, information exposure, cultural narratives
Nocebo effects sit at the intersection of all three.
They are not a flaw in the patient.
They are an adaptive, predictive system working too well in the wrong direction.
Can this be reversed?
Yes. And this is where this framework becomes empowering.
Evidence suggests that nocebo effects can be reduced by:
Careful, balanced communication about treatments
Addressing expectations explicitly
Reducing fear-based interpretations of symptoms
Using psychological approaches (e.g. CBT, DBT, somatic therapies)
Because these responses are learned, they can also be unlearned or reshaped.
A compassionate reframing
If you recognise yourself in this, the most important message is this:
Your symptoms are real.
Your physiology is responding.
Your body is not “broken” — it is protective, adaptive, and highly responsive.
The goal is not to dismiss symptoms, but to understand:
why they are happening
what is amplifying them
and how to gently recalibrate the system
How this shapes care at Sirona Health
This model underpins a more nuanced, personalised approach:
Thoughtful prescribing, minimising nocebo risk
Hormonal care that acknowledges sensitivity patterns
Trauma-informed and expectation-aware consultations
Integration of psychological and physiological treatment strategies
Because for many women, especially those with PMDD, PMS, or perimenopause:
The issue is not just hormones.
It is how the brain and body respond to them.
FAQ
-
No. It produces measurable physiological changes in the body, including pain responses and autonomic activation.
-
Some people have a more responsive nervous system, influenced by genetics, life experiences, hormones, and stress.
-
Quite the opposite. They are real, but may be driven by functional changes rather than structural disease.
-
Yes. Many people benefit from approaches that target nervous system regulation and expectations, alongside or instead of medication.